Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Da Silva

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Plos Pathogens|September 17, 2021
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2Agnieszka M Szemiel, Andres Merits, Richard J Orton, et al.
Plos Biology|December 21, 2021
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defensesVanessa Herder, Kieran Dee, Joanna K Wojtus, et al.
Journal of Viral Hepatitis|January 25, 2022
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmissionAlexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
Plos Pathogens|November 7, 2023
Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learningGavin R Meehan, Vanessa Herder, Jay Allan, et al.
Hepatology (Baltimore, Md.)|November 3, 2018
Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral TreatmentsChris Davis, George S Mgomella, Ana da Silva Filipe, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 9, 2024
The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East AfricaGregory S Orf, Nicholas Bbosa, Michael G Berg, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Elife|September 4, 2019
Interferon lambda 4 impacts the genetic diversity of hepatitis C virusM Azim Ansari, Elihu Aranday-Cortes, Camilla Lc Ip, et al.
Nature Microbiology|January 3, 2025
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemicWilhelm Furnon, Vanessa M Cowton, Giuditta De Lorenzo, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Plos Pathogens|September 17, 2021
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2Agnieszka M Szemiel, Andres Merits, Richard J Orton, et al.
Plos Biology|December 21, 2021
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defensesVanessa Herder, Kieran Dee, Joanna K Wojtus, et al.
Journal of Viral Hepatitis|January 25, 2022
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmissionAlexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
Plos Pathogens|November 7, 2023
Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learningGavin R Meehan, Vanessa Herder, Jay Allan, et al.
Hepatology (Baltimore, Md.)|November 3, 2018
Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral TreatmentsChris Davis, George S Mgomella, Ana da Silva Filipe, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 9, 2024
The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East AfricaGregory S Orf, Nicholas Bbosa, Michael G Berg, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Elife|September 4, 2019
Interferon lambda 4 impacts the genetic diversity of hepatitis C virusM Azim Ansari, Elihu Aranday-Cortes, Camilla Lc Ip, et al.
Nature Microbiology|January 3, 2025
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemicWilhelm Furnon, Vanessa M Cowton, Giuditta De Lorenzo, et al.
Pageof 13